POSTN and cerebritis: In our previous studies, we identified a novel blood-based biomarker panel (beta-amyloid 1-40, Aβ1−40; angiotensin-converting enzyme, ACE; periostin, POSTN; and galectin-3 binding protein, LGALS3BP) to predict cerebral amyloid deposition11,12.